Effectiveness and Safety of Tildrakizumab in Psoriasis Patients Who Failed Anti-IL17 Treatment: A 28-Week Real-Life Study
Clinical, Cosmetic and Investigational Dermatology · 2024-05 · Volume 17 · 1037-1042
DOI: 10.2147/ccid.s464326 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical, Cosmetic and Investigational Dermatology, 2024-05. Verfasst von Matteo Megna und 6 weiteren Autor:innen. Beteiligte Einrichtung: Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
ORCID-Profile: Angelo Ruggiero, Nello Tommasino, Fabrizio Martora, Luca Potestio
Zitieren
APA
Megna, M., Ruggiero, A., Tommasino, N., Brescia, C., Martora, F., Cacciapuoti, S., & Potestio, L. (2024). Effectiveness and Safety of Tildrakizumab in Psoriasis Patients Who Failed Anti-IL17 Treatment: A 28-Week Real-Life Study. Clinical, Cosmetic and Investigational Dermatology, Volume 17, 1037-1042. https://doi.org/10.2147/ccid.s464326
Vancouver
Megna M, Ruggiero A, Tommasino N, Brescia C, Martora F, Cacciapuoti S, et al. Effectiveness and Safety of Tildrakizumab in Psoriasis Patients Who Failed Anti-IL17 Treatment: A 28-Week Real-Life Study. Clinical, Cosmetic and Investigational Dermatology. 2024;Volume 17:1037-1042. doi:10.2147/ccid.s464326
BibTeX
@article{Megna2024,
author = {Megna, Matteo and Ruggiero, Angelo and Tommasino, Nello and Brescia, Claudio and Martora, Fabrizio and Cacciapuoti, Sara and Potestio, Luca},
title = {Effectiveness and Safety of Tildrakizumab in Psoriasis Patients Who Failed Anti-IL17 Treatment: A 28-Week Real-Life Study},
journal = {Clinical, Cosmetic and Investigational Dermatology},
year = {2024},
volume = {Volume 17},
pages = {1037--1042},
doi = {10.2147/ccid.s464326}
}
EUVIMED